Clinical Trial Update: Immersive Virtual Reality (VR) at the Time of Clinical Evaluation to Improve Psychological Distress and Anxiety in Primary Brain Tumor (PBT) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immersive virtual reality delivered at clinical evaluation to reduce psychological distress and anxiety in patients with primary brain …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Brain Tumor

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anxiety | Phase 2 | Status: COMPLETED | Results posted: 2026-03-11